Nurix Therapeutics, Inc. (NRIX)
26.21
-0.66
(-2.47%)
USD |
NASDAQ |
Aug 28, 16:00
26.19
-0.02
(-0.08%)
After-Hours: 20:00
Nurix Therapeutics Shares Outstanding (Quarterly) : 103.70M for May 31, 2026
Shares Outstanding (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shares Outstanding (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 103.70M |
| February 28, 2026 | 103.40M |
| November 30, 2025 | 101.81M |
| August 31, 2025 | 76.87M |
| May 31, 2025 | 76.43M |
| February 28, 2025 | 76.23M |
| November 30, 2024 | 75.87M |
| August 31, 2024 | 67.08M |
| May 31, 2024 | 64.36M |
| February 29, 2024 | 49.14M |
| November 30, 2023 | 48.72M |
| August 31, 2023 | 48.50M |
| May 31, 2023 | 47.63M |
| February 28, 2023 | 47.44M |
| November 30, 2022 | 47.17M |
| Date | Value |
|---|---|
| August 31, 2022 | 47.15M |
| May 31, 2022 | 45.04M |
| February 28, 2022 | 44.85M |
| November 30, 2021 | 44.66M |
| August 31, 2021 | 44.56M |
| May 31, 2021 | 44.40M |
| February 28, 2021 | 39.12M |
| November 30, 2020 | 38.86M |
| August 31, 2020 | 12.95M |
| May 31, 2020 | 38.69M |
| February 29, 2020 | 12.95M |
| November 30, 2019 | 38.85M |
| August 31, 2019 | 38.69M |
| May 31, 2019 | 38.69M |
| February 28, 2019 | 12.95M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shares Outstanding (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | 85.23M |
| Gilead Sciences, Inc. | 1.241B |
| TG Therapeutics, Inc. | 153.08M |
| Cue Biopharma, Inc. | 5.229M |
| Keros Therapeutics, Inc. | 19.83M |